WallStreetZenWallStreetZen

NASDAQ: MIRM
Mirum Pharmaceuticals Inc Stock Ownership - Who owns Mirum Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Mirum Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Eric BjerkholtCHIEF FINANCIAL OFFICER2026-06-092,393$26.49
$63.39kBuy
Eric BjerkholtCHIEF FINANCIAL OFFICER2026-06-082,258$92.84
$209.63kSell
Eric BjerkholtCHIEF FINANCIAL OFFICER2026-06-081,175$93.95
$110.39kSell
Eric BjerkholtCHIEF FINANCIAL OFFICER2026-06-081,567$95.12
$149.05kSell
Peter RadovichPRESIDENT AND COO2026-06-0516,988$19.19
$326.00kBuy
Christopher PeetzCHIEF EXECUTIVE OFFICER2026-06-012,602$94.64
$246.25kSell
Christopher PeetzCHIEF EXECUTIVE OFFICER2026-06-0130,000$2.94
$88.08kBuy
Christopher PeetzCHIEF EXECUTIVE OFFICER2026-06-01883$99.66
$88.00kSell
Christopher PeetzCHIEF EXECUTIVE OFFICER2026-06-011,021$98.20
$100.26kSell
Christopher PeetzCHIEF EXECUTIVE OFFICER2026-06-0116,595$95.34
$1.58MSell

1 of 7

MIRM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MIRM insiders and whales buy or sell their stock.

MIRM Shareholders

What type of owners hold Mirum Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Frazier Life Sciences Management LP12.59%7,679,684$764.44MInstitution
Janus Henderson Group PLC11.39%6,945,813$691.39MInstitution
Joshua Makower6.86%4,186,243$416.70MInsider
David M. Mott6.86%4,186,243$416.70MInsider
Peter J. Barris6.86%4,186,243$416.70MInsider
Peter W. Sonsini6.86%4,186,243$416.70MInsider
Patrick J. Heron6.61%4,031,625$401.31MInsider
Blackrock Inc6.31%3,846,530$382.88MInstitution
Frazier Life Sciences IX LP5.85%3,566,912$355.05MInsider
James E. Flynn5.32%3,244,434$322.95MInsider

1 of 3

MIRM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MIRM56.48%43.52%Net BuyingNet Selling
RYTM88.74%11.26%Net SellingNet Buying
CNTA91.39%8.61%Net SellingNet Selling
PTCT86.91%13.09%Net SellingNet Selling
LQDA50.69%49.31%Net SellingNet Selling
View Top Biotech Stocks

Mirum Pharmaceuticals Stock Ownership FAQ

Who owns Mirum Pharmaceuticals?

Mirum Pharmaceuticals (NASDAQ: MIRM) is owned by 111.92% institutional shareholders, 86.23% Mirum Pharmaceuticals insiders, and 0.00% retail investors. Joshua Makower is the largest individual Mirum Pharmaceuticals shareholder, owning 4.19M shares representing 6.86% of the company. Joshua Makower's Mirum Pharmaceuticals shares are currently valued at $415.88M.

If you're new to stock investing, here's how to buy Mirum Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.